HUSSMAN STRATEGIC ADVISORS, INC. - CRISPR THERAPEUTICS AG ownership

Back to all holdings Add to watchlist

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 444 filers reported holding CRISPR THERAPEUTICS AG in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
HUSSMAN STRATEGIC ADVISORS, INC. ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$422,127
-19.1%
9,3000.0%0.08%
-15.6%
Q2 2023$522,102
-30.5%
9,300
-44.0%
0.10%
-18.6%
Q1 2023$750,818
+11.3%
16,6000.0%0.12%
+7.3%
Q4 2022$674,790
-0.8%
16,600
+59.6%
0.11%
-6.0%
Q3 2022$680,000
-46.2%
10,400
-50.0%
0.12%
-46.3%
Q2 2022$1,264,000
+93.6%
20,800
+100.0%
0.22%
+71.7%
Q1 2022$653,000
-17.1%
10,4000.0%0.13%
-26.6%
Q4 2021$788,000
-43.2%
10,400
-16.1%
0.17%
-43.5%
Q3 2021$1,388,000
-7.8%
12,400
+33.3%
0.31%
-1.9%
Q2 2021$1,506,000
+243.1%
9,300
+158.3%
0.31%
+246.7%
Q1 2021$439,000
-71.9%
3,600
-64.7%
0.09%
-78.0%
Q4 2020$1,562,000
-39.0%
10,200
-66.7%
0.41%
-39.4%
Q3 2020$2,559,000
+126.9%
30,600
+99.3%
0.68%
+135.1%
Q2 2020$1,128,000
+73.3%
15,3500.0%0.29%
+64.6%
Q1 2020$651,000
+4.3%
15,350
+49.8%
0.18%
-12.1%
Q4 2019$624,000–10,250–0.20%–
 Download
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q1 2022
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$27,989,04633.20%
Gilfoyle Management LLC 100$4,84215.90%
NEA Management Company, LLC 1,587,854$89,142,1246.80%
ARK Investment Management 7,338,447$411,980,3942.73%
Nikko Asset Management Americas, Inc. 3,533,357$198,327,3282.09%
Del-Sette Capital Management, LLC 33,661$1,889,7291.79%
Ikarian Capital, LLC 200,000$11,228,0001.79%
Ikarian Capital, LLC 200,000$11,228,0001.79%
Merlin Capital, Inc 8,802$494,1441.67%
Green Alpha Advisors, LLC 34,373$1,929,7001.27%
View complete list of CRISPR THERAPEUTICS AG shareholders